System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework

Abel, Kathryn, Agnew, Emily, Amos, James, Armstrong, Natalie, Armstrong-James, Darius, Ashfield, Thomas, Aston, Stephen, Baillie, J. Kenneth, Baldwin, Steven, Barlow, Gavin, Bartle, Victoria, Bielicki, Julia, Brown, Colin, Carrol, Enitan, Clements, Michelle, Cooke, Graham, Dane, Aaron, Dark, Paul, Day, Jeremy, de-Soyza, Anthony, Dowsey, Andrew, Evans, Stephanie, Eyre, David, Felton, Timothy, Fowler, Tom, Foy, Robbie, Gannon, Karen, Gerada, Alessandro, Goodman, Anna, Harman, Tracy, Hayward, Gail, Holmes, Alison, Hopkins, Susan, Howard, Philip, Howard, Alexander, Hsia, Yingfen, Knight, Gwen, Lemoine, Nick, Koh, James, Macgowan, Alasdair, Marwick, Charis, Moore, Catrin, O'Brien, Seamus, Oppong, Raymond, Peacock, Sharon, Pett, Sarah, Pouwels, Koen, Queree, Chris, Rahman, Najib, Sculpher, Mark, Shallcross, Laura, Sharland, Michael, Singh, Jasvinder, Stoddart, Karen, Thomas-Jones, Emma ORCID: https://orcid.org/0000-0001-7716-2786, Townsend, Andrew, Ustianowski, Andrew, Van Staa, Tjeerd, Walker, Sarah, White, Peter, Wilson, Paul, Buchan, Iain, Woods, Beth, Bower, Peter, Llewelyn, Martin and Hope, William 2024. System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework. The Lancet Microbe 5 (5) , e500-e507. 10.1016/S2666-5247(24)00003-X

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (195kB) | Preview

Abstract

Antimicrobial resistance (AMR) threatens human, animal, and environmental health. Acknowledging the urgency of addressing AMR, an opportunity exists to extend AMR action-focused research beyond the confines of an isolated biomedical paradigm. An AMR learning system, AMR-X, envisions a national network of health systems creating and applying optimal use of antimicrobials on the basis of their data collected from the delivery of routine clinical care. AMR-X integrates traditional AMR discovery, experimental research, and applied research with continuous analysis of pathogens, antimicrobial uses, and clinical outcomes that are routinely disseminated to practitioners, policy makers, patients, and the public to drive changes in practice and outcomes. AMR-X uses connected data-to-action systems to underpin an evaluation framework embedded in routine care, continuously driving implementation of improvements in patient and population health, targeting investment, and incentivising innovation. All stakeholders co-create AMR-X, protecting the public from AMR by adapting to continuously evolving AMR threats and generating the information needed for precision patient and population care.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine Centre for Trials Research (CNTRR)
Publisher:	Elsevier
ISSN:	2666-5247
Date of First Compliant Deposit:	30 August 2024
Date of Acceptance:	7 March 2024
Last Modified:	02 Sep 2024 11:22
URI:	https://orca.cardiff.ac.uk/id/eprint/171682

Actions (repository staff only)

Edit Item